John Bennett, a partner in Goodwin’s IP Litigation group, has nearly 20 years of first-chair trial experience in high-stakes disputes involving intellectual property and complex technology. Mr. Bennett has expertise representing both plaintiffs and defendants in IP disputes related to the life sciences, including litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. Mr. Bennett’s engagements have included trial representation before various federal courts and the Patent Trial and Appeal Board, appellate representation before the Federal Circuit and other courts of appeal, alternative dispute advocacy before neutrals and work on numerous patent, trade secret and contract cases involving a variety of technologies including small molecule pharmaceuticals, biologics, and medical technology. Mr. Bennett is also frequently called on to counsel life science clients with respect to their IP portfolios and licensing strategies.

Mr. Bennett also performs pro bono work. His engagements have included appearing as lead counsel in federal litigation against the U.S. Government which led to the release of Francisco Rodriguez-Guardado, a longtime Massachusetts Institute of Technology custodian and father of three U.S. citizen children, who was suddenly incarcerated and threatened with deportation in 2017.





Mr. Bennett’s recent representations include:

  • Lead trial counsel for plaintiff Fresenius Kabi USA LLC in several patent litigations concerning its branded anesthetic portfolio (Diprivan® and Naropin®), including a successful assertion of patents concerning Naropin® in a recent matter before the U.S. District Court, Western District of Texas.
  • Trial and appellate counsel for plaintiff Teva Pharmaceuticals in several patent litigations concerning its blockbuster innovative treatment for multiple sclerosis, Copaxone®, including Teva's trial victory in the U.S. District Court, Southern District of New York. That case was appealed to the U.S. Supreme Court, resulting in a landmark victory for Teva on the standard of review in claim construction in Teva v. Sandoz.
  • Trial and appellate counsel for plaintiff Teva Pharmaceuticals in several patent litigations concerning its branded treatment for Parkinson’s disease, Azilect®. After a consolidated bench trial, the U.S. District Court, District of New Jersey found Teva’s patent valid and infringed.
  • Lead trial counsel for Fresenius Kabi as a defendant in patent litigation concerning the oncology drug KYPROLIS® (carfilzomib) filed in the U.S. District Court, District of Delaware. A favorable settlement was obtained.
  • Trial and appellate counsel for defendant Actavis Pharmaceuticals in several patent litigations concerning the ulcerative colitis drug UCERIS®. The U.S. District Court, District of Delaware ruled at trial that Actavis’s product did not infringe the asserted patents, permitting the launch of Actavis's generic product in 2018. Actavis subsequently obtained an award of attorneys’ fees.
  • Lead trial counsel for defendant International Medication Systems, Ltd. in patent litigation concerning the pharmacologic stress agent Lexiscan® currently pending in the U.S. District Court, District of Delaware.
Professional Activities

Mr. Bennett is a member of the Boston and Massachusetts Bar Associations.

Professional Experience

Prior to joining Goodwin, Mr. Bennett was an associate with Palmer & Dodge in Boston, where his practice focused on intellectual property litigation.


Mr. Bennett has been recognized by Legal 500 for possessing “extensive experience in all aspects of pre-trial and trial” and providing “exceptional results” with “a unique understanding of the interplay between IP, regulatory, and business issues in the pharmaceutical sector.”

  • Managing IP North America, Milestone Case Award, 2016






J.D., 2000
Boston College Law School
B.A., 1996
Dartmouth College

(cum laude with high honors)





U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the First Circuit
U.S. Court of Appeals for the Fifth Circuit
U.S. Court of Appeals for the Tenth Circuit
U.S. District Court for the District of Massachusetts
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.